Exploring how vinpocetine may help improve cognitive issues from fetal alcohol exposure
Official title: Vinpocetine Mediation of Prior Fetal Alcohol Exposure
Funded at Stanford University · NIH-10954146 · Data updated 2026-11-12
This study is looking at how a drug called vinpocetine might help improve thinking and learning skills in people who have cognitive challenges from fetal alcohol exposure, and it will first test the right amount of the drug in animals before moving on to trials with humans.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | September 25, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $362,596 |
| NIH project number | 1R61AA031291-01A1 |
| Project ID | NIH-10954146 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with Fetal Alcohol Spectrum Disorders (FASD) or those who have experienced fetal alcohol exposure.
✕Less likely to help
Patients without a history of fetal alcohol exposure or those not diagnosed with FASD may not benefit from this research.
What this research studies
This research investigates the potential of vinpocetine, a drug that may enhance neuronal plasticity, to treat cognitive impairments caused by fetal alcohol exposure. The study will first establish the effective dose of vinpocetine in animal models of Fetal Alcohol Spectrum Disorders (FASD) to determine the appropriate plasma concentrations needed for human trials. By understanding how different doses affect cognitive function, the research aims to pave the way for future clinical trials that could provide new treatment options for affected individuals.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options for individuals with cognitive impairments due to fetal alcohol exposure.
How similar studies have gone: Previous studies have shown promising results with vinpocetine in animal models, suggesting potential for success in human applications.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Meador, Kimford J — Stanford University
- Study coordinator: Meador, Kimford J
Related research
Other NIH-funded projects on the same topics.
-
Multimodal AI to predict CAR-T patient response and guide safer, smarter cell design
A Stanford team is building AI tools that use patient and CAR-T cell data to predict how well a CAR-T therapy will work and what design changes might boost effectiveness and safety for people with cancer.
-
Community-driven model to reduce overdose deaths through smarter resource use
A Stanford-led project uses a data-driven model to help counties pick the best ways to prevent opioid and stimulant overdoses and save lives.
-
Center for Dissemination and Implementation at Stanford: Research Core
A Stanford-based program is advancing how evidence-based addiction treatments are implemented across settings to help people with substance use disorders receive better care.
-
Center for Dissemination and Implementation At Stanford (C-DIAS)
A center-based program at Stanford aims to speed people who need addiction treatments to get evidence-based care.
-
Mitochondrial structure and neuron health in Alzheimer's and ALS
This grant studies how mitochondrial cristae structure in neurons is controlled and how its disruption may contribute to diseases like Alzheimer's and ALS.
-
Pediatric EMS seizures: simpler age-based midazolam dosing
A nationwide trial at EMS agencies tests whether using fixed, age-based dosing of midazolam for seizures in children improves treatment speed and safety.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.